1. Home
  2. Analysis
  3. Ipratropium-bromide
  4. Omacor

Ipratropium bromide and Omacor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ipratropium bromide (ipratropium bromide) and Omacor (omega-3acid ethyl esters). Common drug interactions include anaemia among females and myopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Ipratropium bromide and Omacor. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Omacor?

Omacor has active ingredients of omega-3acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 2,547 Omacor users. Check the latest studies of Omacor.

On Jul, 13, 2026

18 people who take Ipratropium bromide and Omacor together, and have interactions are studied.

Ipratropium bromide and Omacor drug interactions.

What are the common drug interactions of Ipratropium Bromide and Omacor, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Blood creatinine increased
  3. Glomerular filtration rate decreased
  4. Haemorrhage (bleeding)
  5. Presyncope
  6. Renal disorder (kidney disease)

male:

  1. Myopathy (a muscular disease in which the muscle fibres do not function)
  2. Myositis (inflammation of the muscles)
  3. Bladder cancer

What are the common drug interactions of Ipratropium Bromide and Omacor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Myopathy (a muscular disease in which the muscle fibres do not function)
  2. Myositis (inflammation of the muscles)
  3. Bladder cancer
  4. Anaemia (lack of blood)
  5. Blood creatinine increased
  6. Glomerular filtration rate decreased
  7. Haemorrhage (bleeding)
  8. Presyncope
  9. Renal disorder (kidney disease)

What are the existing conditions these people have? *

  1. Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 14 people, 77.78%
  2. Type 2 Diabetes: 2 people, 11.11%
  3. Asthma: 2 people, 11.11%
  4. Stable Angina (a constant chest pain): 1 person, 5.56%
  5. Diabetes: 1 person, 5.56%
  6. Depression: 1 person, 5.56%
  7. Constipation: 1 person, 5.56%
  8. Cardiac Disorder: 1 person, 5.56%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and Omacor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ipratropium bromide and Omacor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Omacor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ipratropium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omacor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and omega-3acid ethyl esters (the active ingredients of Ipratropium bromide and Omacor, respectively), and Ipratropium bromide and Omacor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.